Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008

Biovail Reaches Settlement Agreement with OSC Staff

  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. reaches-settlement-agreement-with-osc-staff.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-01-07 14:20:46 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

TORONTO--([ BUSINESS WIRE ])--Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced it has reached a settlement agreement with the Staff of the Ontario Securities Commission (OSC) in respect of an investigation of the Company and certain former officers. The settlement agreement, which is subject to approval by the OSC, will be considered at a hearing that has been scheduled for January 9, 2009.

The investigation related to specific accounting and financial disclosure practices, as previously disclosed, that occurred between 2001 and March 2004 and resulted in a Statement of Allegations by the OSC in March 2008. Terms of the settlement agreement are confidential and will be made public if and when approved by the OSC.

The settlement does not include four individuals who were also named in the Statement of Allegations.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at [ www.biovail.com ].

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [ ir@biovail.com ].